article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA. will top $1.9

DEA 51
article thumbnail

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. In lockstep with the FDA’s more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms. Hundreds of other U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Constitutionality of Cannabis: Federal Lawsuit Against DEA, DOJ Proceeds

Marijuana Lawyer Blog

As our Los Angeles marijuana patient attorneys can explain, the crux of the argument by plaintiffs of the claim, first filed in 2017, is that the designation ignores the merits of the drug for medicinal purposes. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40
article thumbnail

HSS Releases Full Recommendation Report for Rescheduling Cannabis: What Will This Mean for Med & Rec Markets?

Veriheal

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. The HSS also pointed out studies with weaker evidence suggesting cannabis can potentially help with conditions like PTSD , epilepsy , and anxiety.

article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. Drug Enforcement Agency (DEA).

article thumbnail

History of Marijuana in Mexico

Cannabis Law Report

In Mexico, with the arrival of Christopher Columbus, the Spaniards imported Cannabis seeds through large ships in order to produce textiles in “La Nueva España”, also using this plant for medicinal use. The plant was then easily forming part of the local culture.

History 105
article thumbnail

CBD Lawsuit Reflects Trucker Termination for THC Tainted Drug Products

The Blunt Truth

We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% That laboratory informed plaintiff that it could not run the tests on the Dixie X as the substance was illegal and contained THC levels well over the federal limit as per DEA regulations.

THC 87